Adjuvant activity of gastrointestinal peptides

Details Adjuvant activity of gastrointestinal peptides Adjuvant activity of gastrointestinal peptides

A - Human Necessities

61

K

A61K 39/39 (2006.01)

Patent

CA 2591044

Gastrointestinal peptides (GPs) have been found to function as vaccine adjuvants, and in particular as mucosal adjuvants. The invention provides an immunogenic composition comprising: (a) a GP adjuvant; and (b) an antigen. The composition is preferably suitable for mucosal administration e.g. intranasal administration.

Selon cette invention, des peptides gastro-intestinaux (GP) fonctionnent en tant qu'adjuvants de vaccin, et plus particulièrement en tant qu'adjuvants des muqueuses. Plus spécifiquement, l'invention concerne une composition immunogène comprenant: (a) un adjuvant de GP, et (b) un antigène. Cette composition est de préférence adaptée à une administration par les muqueuses, par ex. une administration intranasale.

Affiliated with

Also associated with

Rating

Adjuvant activity of gastrointestinal peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adjuvant activity of gastrointestinal peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvant activity of gastrointestinal peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1950822